Vertex Pharmaceuticals Inc
VRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026Score 15/3037% above fair value
$553.15−5.73 (-1.03%)
Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –
Vertex Pharmaceuticals SBC capitalized into inventory by Quarter
SBC capitalized into inventory ($M) ($M)
Vertex Pharmaceuticals SBC capitalized into inventory: $3.70M in Q2 2026, down 5.1% from a year earlier.
Latest, Q2 2026
3.70
Period ended Jun 30, 2026
Change on a year earlier
-5.1%
3.90 in Q2 2025
History
46 quarters
Since Q1 2015
Sources
41
Documents cited below
Where the Q2 2026 figure comes from
Source: Form 10-Q (filed 2026-08-04) ↗
Reported in Form 10-Q / 10-K Note (Stock-based Compensation).
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | SBC capitalized into inventory ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 3.70 | -5.1% | Form 10-Q (filed 2026-08-04) ↗ |
| Q1 2026 | Mar 31, 2026 | 3.50 | +20.7% | Form 10-Q (filed 2026-05-05) ↗ |
| Q4 2025 | Dec 31, 2025 | 3.20 | +3.2% | Form 10-K (filed 2026-02-13) ↗ |
| Q3 2025 | Sep 30, 2025 | 4.40 | +22.2% | Form 10-Q (filed 2025-11-04) ↗ |
| Q2 2025 | Jun 30, 2025 | 3.90 | +39.3% | Form 10-Q (filed 2026-08-04) ↗ |
| Q1 2025 | Mar 31, 2025 | 2.90 | +163.6% | Form 10-Q (filed 2026-05-05) ↗ |
| Q4 2024 | Dec 31, 2024 | 3.10 | +520.0% | Form 10-K (filed 2026-02-13) ↗ |
| Q3 2024 | Sep 30, 2024 | 3.60 | +350.0% | Form 10-Q (filed 2025-11-04) ↗ |
| Q2 2024 | Jun 30, 2024 | 2.80 | +366.7% | Form 10-Q (filed 2025-08-05) ↗ |
| Q1 2024 | Mar 31, 2024 | 1.10 | +175.0% | Form 10-Q (filed 2025-05-06) ↗ |
| Q4 2023 | Dec 31, 2023 | 0.50 | -200.0% | Form 10-K (filed 2026-02-13) ↗ |
| Q3 2023 | Sep 30, 2023 | 0.80 | -366.7% | Form 10-Q (filed 2024-11-05) ↗ |
| Q2 2023 | Jun 30, 2023 | 0.60 | -300.0% | Form 10-Q (filed 2024-08-02) ↗ |
| Q1 2023 | Mar 31, 2023 | 0.40 | +100.0% | Form 10-Q (filed 2024-05-07) ↗ |
| Q4 2022 | Dec 31, 2022 | -0.50 | -266.7% | Form 10-K (filed 2025-02-13) ↗ |
| Q3 2022 | Sep 30, 2022 | -0.30 | -142.9% | Form 10-Q (filed 2023-11-07) ↗ |
| Q2 2022 | Jun 30, 2022 | -0.30 | -123.1% | Form 10-Q (filed 2023-08-02) ↗ |
| Q1 2022 | Mar 31, 2022 | 0.20 | -88.9% | Form 10-Q (filed 2023-05-02) ↗ |
| Q4 2021 | Dec 31, 2021 | 0.30 | -40.0% | Form 10-K (filed 2024-02-15) ↗ |
| Q3 2021 | Sep 30, 2021 | 0.70 | -22.2% | Form 10-Q (filed 2022-10-28) ↗ |
| Q2 2021 | Jun 30, 2021 | 1.30 | +44.4% | Form 10-Q (filed 2022-08-05) ↗ |
| Q1 2021 | Mar 31, 2021 | 1.80 | +50.0% | Form 10-Q (filed 2022-05-06) ↗ |
| Q4 2020 | Dec 31, 2020 | 0.50 | 0.0% | Form 10-K (filed 2023-02-10) ↗ |
| Q3 2020 | Sep 30, 2020 | 0.90 | +80.0% | Form 10-Q (filed 2021-11-03) ↗ |
| Q2 2020 | Jun 30, 2020 | 0.90 | +350.0% | Form 10-Q (filed 2021-07-30) ↗ |
| Q1 2020 | Mar 31, 2020 | 1.20 | +140.0% | Form 10-Q (filed 2021-04-30) ↗ |
| Q4 2019 | Dec 31, 2019 | 0.50 | +400.0% | Form 10-K (filed 2022-02-09) ↗ |
| Q3 2019 | Sep 30, 2019 | 0.50 | -600.0% | Form 10-Q (filed 2020-10-30) ↗ |
| Q2 2019 | Jun 30, 2019 | 0.20 | +100.0% | Form 10-Q (filed 2020-07-31) ↗ |
| Q1 2019 | Mar 31, 2019 | 0.50 | 0.0% | Form 10-Q (filed 2020-05-01) ↗ |
| Q4 2018 | Dec 31, 2018 | 0.10 | -97.7% | Form 10-K (filed 2021-02-11) ↗ |
| Q3 2018 | Sep 30, 2018 | -0.10 | -85.7% | Form 10-Q (filed 2019-10-31) ↗ |
| Q2 2018 | Jun 30, 2018 | 0.10 | -90.0% | Form 10-Q (filed 2019-08-01) ↗ |
| Q1 2018 | Mar 31, 2018 | 0.50 | +66.7% | Form 10-Q (filed 2019-05-01) ↗ |
| Q4 2017 | Dec 31, 2017 | 4.40 | -320.0% | Form 10-K (filed 2020-02-13) ↗ |
| Q3 2017 | Sep 30, 2017 | -0.70 | -177.8% | Form 10-Q (filed 2018-10-25) ↗ |
| Q2 2017 | Jun 30, 2017 | 1 | +11.1% | Form 10-Q (filed 2018-07-26) ↗ |
| Q1 2017 | Mar 31, 2017 | 0.30 | -62.5% | Form 10-Q (filed 2018-04-27) ↗ |
| Q4 2016 | Dec 31, 2016 | -2 | -350.0% | Form 10-K (filed 2019-02-13) ↗ |
| Q3 2016 | Sep 30, 2016 | 0.90 | -30.8% | Form 10-Q (filed 2017-10-30) ↗ |
| Q2 2016 | Jun 30, 2016 | 0.90 | -18.2% | Form 10-Q (filed 2017-07-28) ↗ |
| Q1 2016 | Mar 31, 2016 | 0.80 | -11.1% | Form 10-Q (filed 2017-04-28) ↗ |
| Q4 2015 | Dec 31, 2015 | 0.80 | – | Form 10-K (filed 2018-02-15) ↗ |
| Q3 2015 | Sep 30, 2015 | 1.30 | – | Form 10-Q (filed 2016-10-31) ↗ |
| Q2 2015 | Jun 30, 2015 | 1.10 | – | Form 10-Q (filed 2016-08-01) ↗ |
| Q1 2015 | Mar 31, 2015 | 0.90 | – | Form 10-Q (filed 2016-05-03) ↗ |
Cite this data
StockData. (2026). Vertex Pharmaceuticals SBC capitalized into inventory ($M), quarterly Q1 2015–Q2 2026 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/sbc-cap
See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.